XETR
WCH
Market cap5.23bUSD
Jul 09, Last price
92.00EUR
1D
5.26%
1Q
0.88%
Jan 2017
-6.89%
IPO
-37.90%
Name
Wacker Chemie AG
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Wacker Chemie AG, an international chemical manufacturing group, delivers a wide array of chemical products across the globe through its various subsidiaries. The company structures its operations into four core divisions: Wacker Silicones, Wacker Polymers, Wacker Biosolutions, and Wacker Polysilicon. The Wacker Silicones segment manufactures and supplies a broad spectrum of silicone-based materials, including silanes, siloxanes, silicone fluids, emulsions, elastomers, resins, and fumed silicas. These materials find extensive application within the construction, electronics, automotive, healthcare, and renewable energy industries. Wacker Polymers specializes in providing binders and polymeric additives, notably dispersible polymer powders and vinyl acetate-ethylene dispersions. These products are crucial for sectors such as building and construction, papermaking, adhesives, paints, coatings, and basic chemical production. Within Wacker Biosolutions, the company offers customized biotechnological solutions and catalog items for the fine chemical industry. Its portfolio encompasses pharmaceutical proteins, vaccines, cyclodextrins, cysteine, solid polyvinyl acetate resins, and acetylacetone, which serve as vital components for active pharmaceutical ingredients, food additives, and agrochemicals. Lastly, the Wacker Polysilicon division is responsible for producing ultra-pure polysilicon, a key raw material essential for both the semiconductor and solar energy sectors. Founded in 1914, Wacker Chemie AG has its corporate headquarters in Munich, Germany. It operates as a subsidiary of Dr. Alexander Wacker Familiengesellschaft mbH.
Valuation
Title EUR in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||